Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase. 2007

D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
Department of Virology, Royal Free Hospital, Pond Street, London NW3 2QG, United Kingdom.

We describe an unusual pathway of human immunodeficiency virus type 1 reverse transcriptase resistance during therapy with tenofovir-emtricitabine, characterized initially by the mutations K70E and M184V and later by K70G and M184V, with the two mutations coexisting on the same viral genome. Phenotypic resistance to lamivudine, emtricitabine, abacavir, didanosine, and tenofovir was observed, whereas susceptibility to zidovudine and stavudine was preserved.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068679 Emtricitabine A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS. Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine,Coviracil,Emtriva,Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine
D000068698 Tenofovir An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone. (R)-9-(2-phosphonylmethoxypropyl)adenine,9-(2-Phosphonomethoxypropyl)adenine,9-(2-Phosphonylmethoxypropyl)adenine,9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer,9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098,9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer,9-PMPA (tenofovir),Tenofovir Disoproxil,Tenofovir Disoproxil Fumarate,Viread,Disoproxil Fumarate, Tenofovir,Disoproxil, Tenofovir,Fumarate, Tenofovir Disoproxil
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
May 1994, The Journal of general virology,
D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
November 2003, Clinical and diagnostic laboratory immunology,
D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
November 2003, Antimicrobial agents and chemotherapy,
D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
August 2004, Journal of virology,
D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
November 1994, AIDS research and human retroviruses,
D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
August 2006, Antimicrobial agents and chemotherapy,
D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
February 2015, AIDS research and human retroviruses,
D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
December 1994, Journal of virology,
D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
April 2004, The new microbiologica,
D Bradshaw, and S Malik, and C Booth, and M Van Houtte, and T Pattery, and A Waters, and J Ainsworth, and A M Geretti
February 1994, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!